E13.41
Other specified diabetes mellitus with diabetic mononeuropathy
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code E13.41 refers to a specific form of diabetes mellitus characterized by the presence of diabetic mononeuropathy. This condition involves nerve damage affecting a single nerve due to long-standing high blood sugar levels associated with diabetes. Recognizing this condition is vital for appropriate management and improving patient quality of life.
Causes & Symptoms
Clinical Causes: Prolonged high blood sugar levels damaging nerves Chronic diabetes leading to nerve ischemia Autoimmune responses triggered by diabetes Vascular changes associated with diabetes impairing nerve blood supply
Key Symptoms: Sudden weakness or pain in a specific nerve area Muscle weakness or paralysis in the affected nerve's distribution Numbness, tingling, or loss of sensation in a localized region Difficulty moving certain muscles or feeling sensations properly Pain or discomfort along nerve pathways
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough clinical examination, review of medical history, and specialized tests such as nerve conduction studies and electromyography. Blood tests to assess blood sugar control and exclude other possible causes of nerve damage may also be performed. Imaging studies can help rule out other conditions that mimic nerve involvement.
Treatment Protocols: Treatment focuses on managing blood sugar levels to prevent further nerve damage. Symptomatic relief may include pain management strategies, physical therapy, and occupational therapy to maintain muscle strength and function. In some cases, medications targeting nerve pain are used. Regular monitoring and blood sugar control are key components of ongoing care.
Clinical Advice & FAQs
Billing Guidance
Is E13.41 a billable ICD-10 code?
Yes, E13.41 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E13.41?
Clinical documentation must specify the nature of Other specified diabetes mellitus with diabetic mononeuropathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
